Charles River Laboratories (CRL) Equity Notice: Contact Robbins LLP if you are a Shareholder Who Suffered Significant Losses in Charles River Laboratories International, Inc. – Charles River (NYSE:CRL)
SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action against Charles River Laboratories International, Inc. CRL for wrongdoing between May 5, 2020 and February 21, 2023. Charles River is a full-service, non-clinical global drug development partner with a mission to create healthier lives. For more information, […]